MMRGlobal, Inc. (OTC: MMRF) Penny Stock on the Move!
Penny Stock Explosion!
MMRGlobal, Inc. (OTC: MMRF) has been making an explosive move up in recent weeks; from its $0.02 to base the stock recently surpassed a nickel on continued heavy accumulation.
MMRGlobal, Inc. provides secure and easy-to-use online Personal Health Records and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups through their subsidiary MyMedicalRecords, Inc.,
The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account.
The big story and a driving factor in the recent explosion in price and trading volume comes as MRFF files claims for patent infringement against Walgreen Co. and Quest Diagnostics, Inc. Both were filed in the United States District Court for the Central District of California, case numbers CV 13-00631 and CV 13-00631, respectively. The Company is planning on bringing additional actions and is using the law firm of Liner Grode Stein Yankelevitz Sunshine Regenstreif & Taylor LLP to pursue licensing and infringement matters for both the Company's health IT patents and its biotech IP.
Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma.
On April 15, MMRF announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the Company's anti-CD20 monoclonal antibody assets, U.S. Serial No. 11/855,943, under the title, "Antibodies and Methods for Making and Using Them." This is the first U.S. patent to be granted for the Company's anti-CD20 monoclonal antibodies, which have particular utility in fighting cancers.
On January 21, MRFF granted three separate warrants to purchase 1,000,000 shares of MRFF common stock to Liner Grode Stein Yankelevitz Regenstreif & Taylor as part of the package for providing services to the Company on a fully contingent basis. The warrants vest immediately and have an exercise price of $0.04, $0.08 and $0.12 per share respectively, and all expire on January 21, 2014. END.
MMRF operates in the very lucrative medical records market which exceeded $20 billion in 2012 and will see robust sales in 2013, according to a report called "EMR 2013: The Market for Electronic Medical Records," by Kalorama Information, a publisher of medical markets research.
Conclusion: Currently trading at a market valuation of just over $29 million MMRF has a ton going for it including a shareholder base that swears this stock goes way higher. Currently trading just over $0.05 the stock is technically sound for continue gains. MMRF is a penny stock to watch and might just provide a spectacular trade opportunity in the weeks and months ahead!
to get the inside scoop on MMRF subscribe to OTCMagic.com right now. Also everyone should know, we have something HUGE coming!